TLR9 and Hepatic fibrosis: Accumulation of cytosolic DNA due to reduced DNase II activity triggers aberrant TLR9 signaling, upregulating IFN‐β expression and inducing RIPK1‐dependent necroptotic hepatocyte death, thereby driving liver fibrosis and NAFLD.56